Global bone marrow transplant market 2017-2021


◆タイトル:Global bone marrow transplant market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥374,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥535,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



About Bone Marrow Transplant
Bone marrow transplant is the medical procedure that is performed to replace the damaged or destroyed bone marrow due to infections, disease, or adverse effect of treatment. A normal bone marrow transplant includes transplantation of blood stem cell that travels to the bone marrow to produce new blood cell and thus improves growth of new marrow. When the bone marrow is damaged due to disease, allogeneic transplant is used whereas autologous transplant is used when bone marrow is intact at the start of disease but it gets damaged due to therapy.

Technavio’s analysts forecast the global bone marrow transplant market to grow at a CAGR of 5.39% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global bone marrow transplant market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Bone Marrow Transplant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AllCells
• Lonza
• Merck
• Sanofi

[Other prominent vendors]
• Athersys
• Beike Biotechnology
• BioTime
• bluebird bio
• Caladrius
• Cellular Biomedicine Group
• Cellular Dynamics International (a subsidiary of Fujifilm)
• Cesca Therapeutics
• CHA Biotech
• Chugai Pharmaceutical
• Gamida Cell
• Global Stem Cells Group
• Hemostemix
• Histocell
• Mesoblast
• TiGenix
• Translational Biosciences (a subsidiary of Medistem Panama)

[Market driver]
• Technological advancement
• For a full, detailed list, view our report

[Market challenge]
• Scarcity of donors and its genetical acceptance
• For a full, detailed list, view our report

[Market trend]
• Growing number of registry
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape
• Market overview
• Five forces analysis

PART 06: Market segmentation by transplant type
• Autologous bone marrow transplant
• Allogeneic bone marrow transplant

PART 07: Market segmentation by indication
• Multiple myeloma
• Acute leukemia
• Hodgkin lymphoma
• Non-Hodgkin lymphoma
• Solid tumors
• Others

PART 08: Geographical segmentation
• Bone marrow transplant market in EMEA
• Bone marrow transplant market in Americas
• Bone marrow transplant market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Newer application of bone marrow transplant
• Growing number of registry
• Online services

PART 12: Vendor landscape
• Competitive scenario

PART 13: Key vendor analysis
• AllCells
• Lonza
• Merck
• Sanofi
• Other prominent vendors

PART 14: Appendix
• List of abbreviations


AllCells, Lonza, Merck, Sanofi, Athersys, Beike Biotechnology, BioTime, bluebird bio, Caladrius, Cellular Biomedicine Group, Cellular Dynamics International, Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, CORESTEM, Gamida Cell, Global Stem Cells Group, Hemostemix, Histocell, Mesoblast, TiGenix, and Translational Biosciences





★調査レポート[骨髄移植の世界市場2017-2021:自家骨髄移植、同種骨髄移植] (Global bone marrow transplant market 2017-2021 / IRTNTR13721)販売に関する免責事項
[骨髄移植の世界市場2017-2021:自家骨髄移植、同種骨髄移植] (Global bone marrow transplant market 2017-2021 / IRTNTR13721)についてEメールでお問い合わせ